Ontology highlight
ABSTRACT: Background
The suggestion that the neurohormone oxytocin may have clinical application in the treatment of schizophrenia was first published in 1972. Since then, a considerable body of research on a variety of fronts--including several recent double-blind treatment trials-has buttressed these early reports, providing support for the assertion that the oxytocin system is a promising and novel therapeutic target for this devastating malady. Herein, we review the diverse, convergent lines of evidence supporting the therapeutic potential of oxytocin in psychotic illness.Methods
We performed a systematic review of preclinical and clinical literature pertaining to oxytocin's role in schizophrenia.Results
Multiple lines of evidence converge to support the antipsychotic pot
SUBMITTER: Macdonald K
PROVIDER: S-EPMC3378061 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature